DNA Microarray IndustryThe global DNA microarray Industry is projected to witness robust growth, with its valuation expected to increase from USD 4.1 billion in 2024 to USD 9.9 billion by 2034, ...

The Advances in Microarray Technology Conference, the fourth in the Select BioSciences AMT events, held in Barcelona May 7-8, 2008 was well attended, with more than 400 participants, around 40 ...

Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technologyResearch builds on ...

Arabidopsis thaliana, Meet Microarray Technology Courtesy of Steve Kay Data derived from the Science Watch/Hot Papers database and the Web of Science (ISI, Philadelphia) show that Hot Papers are cited ...

Biolog, Inc. announced today that it has received another patent on its Phenotype MicroArray™ technology, extending the breadth and depth of its unique portfolio of intellectual property. Patent US ...

Research builds on Emory's research on influenza vaccines self-administered via Micron's microarray technology ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Emory University and Micron Biomedical today ...

Welcome to the 4th annual Advances in Microarray Technology (AMT) conference where you will hear about the latest developments and applications in the rapidly expanding field of microarrays.

A two-stage painless pimple patch set with an array of tiny spikes grabs onto pimples and delivers antibacterial or ...